Scott Moss, the vice president and general manager of Dexcom Asia Pacific, discusses the recently announced dramatic expansion in funded access to continuous glucose monitoring and future developments in the management and treatment of insulin-dependent diabetes.
New Stories
-
Dr Rachel David: Let’s get real about what’s ailing private hospitals
March 19, 2024 - Policy -
HBF to adjust branch network as digital interactions with members increase
January 31, 2024 - Latest News -
Insurers say Medicare has served Australia well but it’s time for a mid-life health check
January 31, 2024 - Latest News -
Health funds call for ‘surprise billing law’ in response to higher costs for procedures
January 31, 2024 - Latest News -
Science & Technology Australia slams Budget 'raid' on support for commercialisation
December 14, 2023 - Latest News -
Budget update confirms the creation of Genomics Australia delayed until mid-2025
December 14, 2023 - Latest News -
Medibank releases its top private health insurance claims for 2023
December 14, 2023 - Latest News